Related Experiment Video
Updated: Nov 7, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Expert recommendations based on link prediction during the COVID-19 outbreak
1College of Computer Science and Technology, Zhejiang University of Technology, Hangzhou, 310023 PR China.
Insights
This study introduces a novel AI model to connect researchers, fostering collaboration for faster COVID-19 vaccine and therapeutic drug development. The graph neural network (GNN) + long short-term memory (LSTM) + generative adversarial network (GAN) model predicts expert connections to overcome research silos.
Area of Science:
- Computer Science
- Artificial Intelligence
- Bioinformatics
Background:
- The COVID-19 pandemic has led to a surge in infections and deaths globally.
- Despite research efforts, effective vaccines and therapeutics are still under development, with limited interdisciplinary cooperation.
- Information silos and redundant research hinder progress in finding COVID-19 solutions.
Purpose of the Study:
- To analyze features of expert cooperation networks to identify potential collaborators.
- To develop a novel expert recommendation model to encourage interdisciplinary and multinational research cooperation.
- To accelerate the development of therapeutic drugs and vaccines for COVID-19.
Main Methods:
- Comprehensive analysis of expert cooperation network features, including graph structure, context attributes, and sequential co-occurrence probability.
- Construction of a novel Graph Neural Network (GNN) + Long Short-Term Memory (LSTM) + Generative Adversarial Network (GAN) model.
- Application of link prediction techniques within the developed GNN+LSTM+GAN model to recommend expert collaborators.
Main Results:
- The study provides a framework for analyzing expert networks and identifying key features for collaboration.
- The proposed GNN+LSTM+GAN model demonstrates potential for predicting and recommending expert connections.
- The model aims to facilitate the formation of cooperative relationships among researchers in social networks.
Conclusions:
- Enhanced expert collaboration is crucial for accelerating the development of COVID-19 vaccines and therapeutics.
- The developed AI model offers a promising approach to overcoming research fragmentation and promoting cross-field cooperation.
- Facilitating multinational and cross-field expert partnerships is significant for global health challenges.
Abstract:
Since the emergence of COVID-19, the number of infections has significantly increased. As of April 7, 8:00 am, the total number of global infections has already reached 1,338,415, with the number of deaths being 74,556. Medical experts from various countries have conducted relevant researches in their own fields and countries, and the development of an effective vaccine has been expected soon. Although some progress has been made in the development of therapeutic drugs and vaccines, interdisciplinary and cooperative studies are scarce. However, it is easy to form information islands and conduct repeated scientific research. To date, no therapeutic drug or vaccine for COVID-19 has been officially approved yet for marketing. In this article, the features of experts in cooperation networks, such as graph structure, context attribute, sequential co-occurrence probability, weight features and auxiliary features, are comprehensively analyzed. Based on this, a novel graph neural network + long short-term memory + generative adversarial network (GNN + LSTM + GAN) expert recommendation model based on link prediction is constructed to encourage cooperation among relevant experts in research social networks. Finding experts in related fields, establishing cooperative relations with them and achieving multinational and cross-field expert cooperation are significant to promote the development of therapeutic drugs and vaccines.
Related Concept Videos
Steps in Outbreak Investigation
Single Nucleotide Polymorphisms-SNPs
Causality in Epidemiology
Outliers and Influential Points
Principles of Disease Surveillance
Statistical Methods for Analyzing Epidemiological Data

